IP Library Assignment 064277/0533
Patent Assignment
Reel/Frame 064277/0533

Assignment of Assignor's Interest

Recorded: 2023-07-17 Pages: 6
Assignor
CADENT THERAPEUTICS, INC.
Executed: 2022-12-01
Assignee
NOVARTIS AG
LICHTSTRASSE 35, BASEL, 4056, SWITZERLAND
Covered Property (1)
Pyrazine Derivatives and Their Use as Potassium Channel Modulators
Patent: 8,415,358 →
Application: 12/678,244 →
Publication: US 2010/0286161
Related Assignments (6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jun 2, 2010
From: ERIKSEN, BIRGITTE L.; SORENSEN, ULRIK SVANE; HOUGAARD, CHARLOTTE; PETERS, DAN
To: NEUROSEARCH A/S
Reel/Frame 024475/0329 →
Corrective Assignment to Correct the Docket Number. Previously Recorded on Reel 024475 Frame 0329. Assignor(S) Hereby Confirms the Correct Docket Number Is 2815-0424PUS2. Sep 16, 2010
From: ERIKSEN, BIRGITTE L.; SORENSEN, ULRIK SVANE; HOUGAARD, CHARLOTTE; PETERS, DAN
To: NEUROSEARCH A/S
Reel/Frame 024997/0092 →
Assignment of Assignor's Interest Mar 20, 2013
From: NEUROSEARCH A/S
To: ANIONA APS
Reel/Frame 030049/0894 →
Assignment of Assignor's Interest Aug 6, 2013
From: ANIONA APS
To: ATAXION, INC.
Reel/Frame 030946/0329 →
Merger Jul 17, 2023
From: ATAXION, INC.
To: LUC THERAPEUTICS, INC.
Reel/Frame 064277/0494 →
Change of Name Jul 17, 2023
From: LUC THERAPEUTICS, INC.
To: CADENT THERAPEUTICS, INC.
Reel/Frame 064277/0542 →